West Pharmaceutical Services マネジメント
マネジメント 基準チェック /44
West Pharmaceutical Servicesの CEO はEric Greenで、 Apr2015年に任命され、 の在任期間は 9.58年です。 の年間総報酬は$ 9.40Mで、 12.1%給与と87.9%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.23%を直接所有しており、その価値は$ 51.70M 。経営陣と取締役会の平均在任期間はそれぞれ4.5年と9.5年です。
主要情報
Eric Green
最高経営責任者
US$9.4m
報酬総額
| CEO給与比率 | 12.1% |
| CEO在任期間 | 9.6yrs |
| CEOの所有権 | 0.2% |
| 経営陣の平均在職期間 | 4.5yrs |
| 取締役会の平均在任期間 | 9.5yrs |
経営陣の近況
Recent updates
West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next
Oct 27
West Pharma's Destocking Dilemma: Why Staying On The Sidelines Makes Sense
Oct 11Getting In Cheap On West Pharmaceutical Services, Inc. (NYSE:WST) Is Unlikely
Sep 20A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)
Sep 02West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 28West Pharmaceutical: Continued Destocking And A High Valuation Post Q2 Results (Rating Maintained)
Jul 25Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?
Jul 15We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt
Jun 27Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)
May 21West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry
May 11West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price
Mar 30Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?
Mar 12Why West Pharma Is Far From Done
Feb 28West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price
Feb 20West Pharmaceutical Services: Still Too Expensive After The Recent Drop
Feb 20What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?
Jan 10West Pharmaceutical: Great Business, Not So Great Valuation
Jan 08What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You
Dec 18West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Nov 27West Pharmaceutical Services: The Run Might Be Over
Oct 18Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?
Sep 24Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
Aug 22West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
Aug 08What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?
Jun 26West Pharmaceutical: Hard To Justify The Price
May 26Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?
May 16At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?
Mar 20West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture
Feb 28West Pharmaceutical Q4 2022 Earnings Preview
Feb 15West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Jan 31West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive
Dec 19West Pharmaceutical declares $0.19 dividend
Dec 13Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching
Nov 29CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$500m |
| Jun 30 2024 | n/a | n/a | US$525m |
| Mar 31 2024 | n/a | n/a | US$569m |
| Dec 31 2023 | US$9m | US$1m | US$593m |
| Sep 30 2023 | n/a | n/a | US$559m |
| Jun 30 2023 | n/a | n/a | US$519m |
| Mar 31 2023 | n/a | n/a | US$552m |
| Dec 31 2022 | US$8m | US$1m | US$586m |
| Sep 30 2022 | n/a | n/a | US$631m |
| Jun 30 2022 | n/a | n/a | US$686m |
| Mar 31 2022 | n/a | n/a | US$684m |
| Dec 31 2021 | US$9m | US$1m | US$662m |
| Sep 30 2021 | n/a | n/a | US$613m |
| Jun 30 2021 | n/a | n/a | US$519m |
| Mar 31 2021 | n/a | n/a | US$423m |
| Dec 31 2020 | US$8m | US$989k | US$346m |
| Sep 30 2020 | n/a | n/a | US$312m |
| Jun 30 2020 | n/a | n/a | US$286m |
| Mar 31 2020 | n/a | n/a | US$261m |
| Dec 31 2019 | US$7m | US$936k | US$242m |
| Sep 30 2019 | n/a | n/a | US$230m |
| Jun 30 2019 | n/a | n/a | US$229m |
| Mar 31 2019 | n/a | n/a | US$219m |
| Dec 31 2018 | US$5m | US$880k | US$207m |
| Sep 30 2018 | n/a | n/a | US$155m |
| Jun 30 2018 | n/a | n/a | US$151m |
| Mar 31 2018 | n/a | n/a | US$133m |
| Dec 31 2017 | US$5m | US$824k | US$151m |
報酬と市場: Ericの 総報酬 ($USD 9.40M ) は、 US市場 ($USD 12.87M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Ericの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Eric Green (54 yo)
9.6yrs
在職期間
US$9,395,896
報酬
Mr. Eric M. Green serves as Independent Director at Ecolab Inc. since December 08, 2022. He has been the Chief Executive Officer of West Pharmaceutical Services, Inc. since April 24, 2015 and its President...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Non-Independent Chair of the Board | 9.6yrs | US$9.40m | 0.23% $ 51.7m | |
| Senior VP & CFO | 6.4yrs | US$3.64m | 0.0095% $ 2.1m | |
| Senior VP & CTO | 3.9yrs | US$1.67m | 0.0040% $ 880.9k | |
| Senior VP | 3.9yrs | US$1.49m | 0.0019% $ 419.3k | |
| Senior VP & Chief Commercial Officer | 5yrs | US$1.53m | 0.0067% $ 1.5m | |
| VP, Chief Accounting Officer & Corporate Controller | 5.1yrs | データなし | 0.0018% $ 403.6k | |
| Head of Investor Relations | no data | データなし | データなし | |
| Vice President of Global Communications | no data | データなし | データなし | |
| Senior VP of Strategy & Corporate Development | less than a year | データなし | データなし | |
| Chief Human Resources Officer & Senior VP | 9.1yrs | US$1.14m | 0.0090% $ 2.0m | |
| Senior VP and Chief Quality & Regulatory Officer | 2.5yrs | データなし | データなし | |
| President of Contract Manufacturing | less than a year | データなし | データなし |
4.5yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: WSTの経営陣は 経験豊富 であると考えられます ( 4.5年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Non-Independent Chair of the Board | 9.5yrs | US$9.40m | 0.23% $ 51.7m | |
| Independent Director | 10.8yrs | US$359.35k | 0.024% $ 5.3m | |
| Independent Director | 4.8yrs | US$330.66k | 0.0034% $ 749.3k | |
| Independent Director | 17.1yrs | US$390.35k | 0.059% $ 13.2m | |
| Independent Director | 13.8yrs | US$378.23k | 0.056% $ 12.5m | |
| Independent Director | 13.8yrs | US$377.01k | 0.059% $ 13.2m | |
| Lead Independent Director | 8.2yrs | US$367.44k | 0.012% $ 2.7m | |
| Independent Director | 2.3yrs | US$331.46k | 0.0015% $ 330.1k | |
| Independent Director | 12.8yrs | US$362.83k | 0.040% $ 9.0m | |
| Independent Director | 7.4yrs | US$333.45k | データなし | |
| Honorary Director | no data | データなし | データなし | |
| Independent Director | 3.3yrs | US$321.43k | 0.00087% $ 194.0k |
9.5yrs
平均在職期間
63yo
平均年齢
経験豊富なボード: WSTの 取締役会 は 経験豊富 であると考えられます ( 9.5年の平均在任期間)。